Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to try and understand if there is added benefit or increased
harm when antioxidant nutritional supplements are added to traditional chemotherapy in the
treatment of ovarian cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Jeanne Drisko, MD, CNS, FACN
Collaborators:
Cancer Treatment Research Foundation University of Kansas Medical Center
Treatments:
Albumin-Bound Paclitaxel alpha-Tocopherol Antioxidants Ascorbic Acid Carboplatin Carotenoids Paclitaxel Retinol palmitate Tocopherols Tocotrienols Vitamin A Vitamin E Vitamins